Please use this identifier to cite or link to this item: http://hdl.handle.net/10419/235520
Authors: 
Albanese, Andrea
Fallucchi, Francesco
Verheyden, Bertrand
Year of Publication: 
2021
Series/Report no.: 
GLO Discussion Paper No. 878
Abstract: 
Over the first half of March 2021, the majority of European governments suspended Astrazeneca's Vaxzevria vaccine as a precaution following media reports of rare blood clots. We analyse the impact of the European Medicines Agency's (EMA) March 18th statement assuring the public of the safety of Vaxzevria and the immediate reinstatement of the vaccine by most countries on respondents' intention to get vaccinated. By relying on survey data collected in Luxembourg and neighbouring areas between early March and mid-April, we observe that the willingness to be vaccinated was severely declining in the days preceding the EMA statement. We implement a regression discontinuity design exploiting the time at which respondents completed the survey and find that the vaccine reinstatement substantially restored vaccination intentions.
Subjects: 
COVID-19
vaccine hesitancy
supranational regulation
public health
regression discontinuity design
JEL: 
I12
I18
C21
H12
H40
Document Type: 
Working Paper

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.